Related Experiment Video
Updated: Jul 15, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Reduction in event-related alpha attenuation during performance of an auditory oddball task in schizophrenia
Masato Higashima1, Takahiro Tsukada, Tatsuya Nagasawa
1Department of Psychiatry and Neurobiology, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan. mtohma@med.kanazawa-u.ac.jp
Abstract:
EEG frequency-domain analyses have demonstrated that cognitive performance produces a reduction in alpha activity, i.e., alpha attenuation, such as event-related desynchronization (ERD), reflecting brain activation. To examine whether schizophrenic patients have abnormalities in frequency-domain, event-related alpha attenuation, as well as in time-domain EEG phenomena, such as event-related potential, we compared alpha power change and P300 elicited simultaneously in response to the presentation of target tones in an auditory oddball paradigm between patients with schizophrenia and normal control subjects. In both patients and controls, alpha power was smaller during the time window of 512 ms following targets than following non-targets, particularly at the parietal and the posterior temporal locations (Pz, T5, and T6). The size of alpha attenuation measured as percent reduction in alpha power produced by targets relative to non-targets was smaller in patients than in controls at the posterior temporal locations. The size of alpha attenuation showed no correlation with P300 amplitude or latency in either patients or controls. Furthermore, in patients, the size of alpha attenuation showed no correlation with symptom severity, while P300 amplitude was correlated negatively with the positive subscale score of the Positive and Negative Syndrome Scale. These findings suggest that the symptom-independent reduction in event-related alpha attenuation in schizophrenia may be useful as an electrophysiological index of the impairment of neural processes distinct from that indexed by symptom-dependent P300 abnormalities.

